Leonard Braden Michael Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
78
Insider Buys Sum
$19.52M
Insider Sells Quantity
51
Insider Sells Sum
$28.82M

Insider Activity of Leonard Braden Michael

According to the SEC Form 4 filings, Leonard Braden Michael, being in a position of

  1. 10 percent owner at Aclaris Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 300000 shares for $1.36M,
    over all time since 2024-06-11, has bought 4854052 shares for $5.59M, and sold 300000 shares for $1.36M.

Biography of Leonard Braden Michael

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $870,260267
Sells
 $1,359,000133

Comparison of Insiders on Amount of Buys and Sells

2026-10-02PurchaseOutset Medical, Inc.
OM
10 percent owner
16,575
0.0871%
$3.88$64,241+3.16%
2026-10-01PurchaseOutset Medical, Inc.
OM
10 percent owner
228,334
1.1544%
$3.53$806,019+8.8%
2026-04-23SaleAclaris Therapeutics, Inc.
ACRS
10 percent owner
300,000
0.2477%
$4.53$1.36M+10.11%
2025-10-03SaleAstrotech Corporation
ASTC
10 percent owner
220,410
19.1709%
$7.13$1.57M-35.8%
2025-10-03SaleAstrotech Corporation
ASTC
10 percent owner
229,576
19.8228%
$7.08$1.63M-35.8%
2025-05-30SaleAN2 Therapeutics, Inc.
ANTX
10 percent owner
432,000
1.3646%
$1.01$436,477+9.43%
2025-05-28SaleAN2 Therapeutics, Inc.
ANTX
10 percent owner
200,000
0.6282%
$1.09$218,000+0.87%
2025-05-28SaleAN2 Therapeutics, Inc.
ANTX
10 percent owner
2.1M
7.0198%
$1.16$2.44M+0.87%
2024-08-14PurchaseAN2 Therapeutics, Inc.
ANTX
10 percent owner
1.5M
3.1264%
$1.04$1.56M+7.62%
2024-08-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
206,025
0.2901%
$1.24$256,357+24.6%
2024-08-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
167,544
0.2372%
$1.29$216,400+20.31%
2024-07-31PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
100,000
0.1421%
$1.33$132,640+14.55%
2024-07-30PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
173,730
0.2425%
$1.30$226,370+17.18%
2024-07-22PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
17,716
0.0249%
$1.33$23,557+13.91%
2024-07-19PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
6,689
0.0092%
$1.30$8,696+12.88%
2024-07-18PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
130,317
0.1816%
$1.30$169,555+13.74%
2024-07-05PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
123,017
0.1779%
$1.15$141,334+20.83%
2024-07-03PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
143,288
0.209%
$1.16$166,071+26.09%
2024-07-02PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
86,092
0.1239%
$1.14$98,489+27.19%
2024-07-01PurchaseAclaris Therapeutics, Inc.
ACRS
10 percent owner
107,434
0.1538%
$1.14$122,185+25.65%
Total: 107
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.